Parvovirus B19 in stem cell transplantation

Transpl Infect Dis. 2023 Oct;25(5):e14138. doi: 10.1111/tid.14138. Epub 2023 Aug 23.

Authors

Paul M Kinsella^{1

2}, Michelle K Yong^{1

3

4}, Monica A Slavin^{1

3

4}, Victoria G Hall^{1

3}

Affiliations

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
⁴ Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Victoria, Australia.

PMID: 37610327
DOI: 10.1111/tid.14138

No abstract available

Keywords: hematopoietic cell transplantation; immunocompromised; immunodeficiency; intravenous immunoglobulin; parvovirus B19.

Publication types

Editorial

MeSH terms

Erythema Infectiosum*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Parvoviridae Infections*
Parvovirus B19, Human*
Stem Cell Transplantation / adverse effects

Grants and funding

#2014210 VGH/National Health and Medical Research